<DOC>
	<DOCNO>NCT02940470</DOCNO>
	<brief_summary>The primary objective pilot study determine effect weight loss wide range biomarkers associate risk breast cancer recurrence overweight obese breast cancer survivor . We hypothesize weight loss would result statistically significant improvement biomarkers associate risk breast cancer recurrence .</brief_summary>
	<brief_title>Weight Loss Pilot Study Postmenopausal Breast Cancer Survivors</brief_title>
	<detailed_description>Women overweight , obese gain weight breast cancer diagnosis great risk recurrence death compare light woman . There study examine effect different intervention weight loss breast cancer survivor examine effect weight loss intervention circulate level marker associate cancer risk . The overall objective proposal determine weight loss affect circulate level biomarkers associate breast cancer risk recurrence , quality life overweight obese breast cancer survivor . The central hypothesis weight loss decrease level marker adversely associate breast cancer increase quality life woman . To test central hypothesis follow specific aim pursue : - To assess effect two different weight loss intervention biomarkers associate breast cancer risk recurrence - To assess impact weight loss intervention quality life sleep - To assess impact weight loss measure bone health</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>postmenopausal ( defined experience least 12 month without menstrual period ) diagnose operable invasive breast cancer treat mastectomy lumpectomy radiation complete surgery , radiation , systemic chemotherapy one 12 month prior enrollment BMI â‰¥ 27 kg/m2 less 7 serving alcohol per week willing randomize either group planning move away area period study nonsmoker serious illness require medical treatment inability participate physical activity due severe disability history schizophrenia , psychosis untreated major depression unwilling commute study site per week failure provide write informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>44 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>